| Condition | Key Finding | Association | Board Exam Tip |
| Silicosis (Chronic) | Upper/Lower lobe nodules; X-shell calcification | Low level, prolonged exposure (>10 years); Coal miners, sandblasters. | Pathognomonic finding is peripheral hilar lymph node calcifications ("X-shell"). |
| Acute Silicosis / Silica Proteinosis | Ground glass opacities; Crazy paving pattern on CT | Very high intensity exposure (weeks to 5 years); Engineered stone fabrication. | Pathology mimics Pulmonary Alveolar Proteinosis (PAP). |
| OSHA PEL/Action Level | 50 g/m^3 / 25 g/m^3 | Monitoring and Surveillance Triggers; ACGI TLV (25 g/m^3). | Remember the numbers: 50 is the limit, 25 triggers monitoring. |
| Engineered Stone Exposure | Rapidly progressive silicosis in young workers | High crystalline silica content (90-95%); Countertop fabrication. | This is an emerging and highly testable topic; think acute/accelerated disease in a young demographic. |
| Topic | Key Point | Context | Exam Relevance |
| OSHA PEL | 50 g/m^3 (8-hr TWA) | Maximum permissible exposure limit for respirable silica. | Exceeding this mandates mandatory engineering controls and a written plan. |
| Action Level | 25 g/m^3 | Threshold that triggers monitoring and medical surveillance obligations. | If exposed 25 g/m^3 for 30+ days/year, surveillance is required. |
| Periodic Exam Interval | Every three years | Required component of medical surveillance protocol. | Common board trap: Do not assume annual exams are needed; it is every three years. |
| Acute Silicosis Pathophysiology | Alveolar filling with proteinaceous material (PES positive) | Result of massive, short-term silica exposure (e.g., engineered stone). | Radiographically mimics Pulmonary Alveolar Proteinosis (PAP); look for "crazy paving." |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A foundry worker presents with bilateral upper lobe nodules, peripheral hilar calcifications, and a restrictive PFT pattern. | Chronic Silicosis | Classic finding: Upper/lower predominant nodularity and pathognomonic "X-shell" (peripheral) lymph node calcification. |
| A young countertop fabricator develops rapid lung failure characterized by ground glass opacities and alveolar filling with proteinaceous material. | Acute Silicosis / Silica Proteinosis | Short latency (<5 years), high exposure, and pathology mimicking pulmonary alveolar proteinosis are hallmarks of acute silica toxicity. |
| An industrial hygienist finds worker exposures consistently between 20-46 g/m^3 (above AL but below PEL). | No immediate medical surveillance required (unless 30+ days) | Medical surveillance is triggered by the Action Level (25 g/m^3) and the 30-day threshold, not just being above a certain concentration. |
| A patient with silicosis presents with signs of systemic sclerosis and anti-centromere antibodies. | Silica-associated Scleroderma | Highlights the known autoimmune association; silica exposure can trigger connective tissue diseases. |
| An employer uses specific equipment listed in Table I (Construction Standard) for dust suppression. | Exemption from Air Monitoring | Compliance with the detailed controls of Table I allows an exemption from mandatory air monitoring, provided the controls are followed correctly. |
| A worker is exposed to silica and subsequently develops active pulmonary tuberculosis. | Increased TB Risk | Silica impairs alveolar macrophage function, leading to a 3-4 fold increased risk of developing active TB. |
| Key Features | Distinguishing Findings | Next Step |
| Silicosis | Nodular pattern (Chronic); Alveolar filling (Acute). Calcifications of hilar nodes. | Occupational history is paramount; rule out other pneumoconioses. |
| Pulmonary Alveolar Proteinosis (PAP) | Ground glass opacities, alveolar lining filled with proteinaceous material. | Often idiopathic or secondary to silica exposure; requires high suspicion based on clinical context/CT findings. |
| Condition | Association | Mechanism | Clinical Significance |
| Silicosis | Lung Cancer (IARC Group 1) | Chronic inflammation; generation of reactive oxygen species (ROS); impaired DNA repair. | Requires mandatory screening and awareness due to high carcinogenic risk. |
| Silicosis | Tuberculosis (TB) | Silica is toxic to alveolar macrophages, impairing immune defense against M. tuberculosis. | Leads to a 3-4 fold increased risk of active TB; mandates IGRA/TST testing. |
| Silicosis | Systemic Sclerosis / Lupus | Chronic inflammation and mineral deposition trigger autoimmune responses. | The scleroderma link is particularly well-established and frequently tested. |
| Engineered Stone Fabrication | Acute Silicosis (Silica Proteinosis) | High concentration of crystalline silica (90–95%) generated during grinding/polishing. | Leads to rapid, severe lung disease in young workers; requires immediate hazard control. |
| Term | Definition | Context | Example |
| PEL | Permissible Exposure Limit (50 g/m^3) | OSHA standard for the maximum allowable 8-hour TWA exposure to silica. | If air monitoring exceeds 50 g/m^3, mandatory engineering controls are required. |
| Action Level (AL) | Threshold of concern (25 g/m^3) | The level that triggers medical surveillance and monitoring obligations, even if below the PEL. | Exposure 25 g/m^3 for 30+ days/year mandates a full medical workup. |
| ILO Classification | International Labour Organization classification system | Standardized method used by NIOSH-certified readers to grade pneumoconiosis findings on chest radiographs (e.g., profusion grades). | Used to quantify the severity of nodular opacities in silicosis. |
| Crazy Paving Pattern | Ground glass opacities with superimposed reticular/linear markings. | Characteristic CT finding associated with acute silica exposure or pulmonary alveolar proteinosis. | Highly suggestive of severe, acute lung injury from high-level silica inhalation. |
| Topic | Study Approach | Priority | Resources |
| Exposure Limits | Memorize the numbers and their triggers (PEL vs AL). | High | Flashcards/Quick Fire Review; Compare PEL (50) to ACGI TLV (25). |
| Silicosis Differential Diagnosis | Create a comparison table based on latency, exposure level, and pathology. | Medium-High | Use the three types (Chronic, Accelerated, Acute) as anchors for differential reasoning. |
| Protocols & Surveillance | Focus on "when" things are required: 30 days/year; every 3 years; written opinion limitations. | High | Practice questions focusing on trigger thresholds and mandatory steps. |